ArticlePharmaceutics2022

A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline.

Romain Pelletier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.